Skip to main content

Table 2 Clinical characteristics of the 7 patients diagnosed with cyclosporine A-related neurotoxicity

From: Cyclosporine A-related neurotoxicity after haploidentical hematopoietic stem cell transplantation in children with hematopathy

Patient number #1 #2 #3 #4 #5 #6 #7
Gender M F M M F M M
Age at HID-HSCT (years) 8 7 7 9 8 7 4
Underlying disease MDS ALL AML MDS-SAML AML AML ALL
Remission status NR CR1 CR1 CR1 CR1 CR1 PR
HLA typing 6/10 5/10 7/10 5/10 5/10 5/10 5/10
Donor-recipient gender F-M F-F F-M F-M M-F M-M M-M
ABO type of donor and recipient Matched Mismatched Mismatched Mismatched Matched Mismatched Matched
Mononuclear cells (× 108/kg) 6.14 13.1 17.5 17.45 5.6 1.82 16.37
CD34+ cells (×106/kg) 2.3 2.5 6.85 3.17 8.81 10.14 5.33
Neutrophil engraftment time (days) 11 10 11 19 12 16 10
Thrombocyte engraftment time (days) 15 10 11 22 12 17 10
  1. ALL Acute lymphoblastic leukemia, AML Acute myeloid leukemia, CR Complete remission, F Female, HID-HSCT Haploidentical hematopoietic stem cell transplantation, M Male, MDS-SAML Myelodysplastic syndrome-secondary acute myeloid leukemia, NR No response, PR Partial remission